Cardiac test assessment method, system and apparatus, and storage medium

MYPI2025004190A0Undetermined Publication Date: 2024-07-10BISHENGPU BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025004190
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-01-10
Filing Date
2023-05-11
Publication Date
2024-07-10

AI Technical Summary

Technical Problem

Traditional ECG monitors have low sensitivity and accuracy when detecting heart health conditions, making it difficult to detect heart problems and changes in condition in a timely manner, especially in terms of myocardial ischemia and heart failure.

Method used

Through the analysis of high-frequency ECG components, ECG signals are collected and abnormal data is identified, including heart rate, blood oxygen, blood pressure, etc., and the high-frequency morphological index and envelope curve decline times are calculated using the high-frequency morphological index of QRS wave group data. times, if it exceeds the preset threshold, an alarm reminder will be output to achieve early detection of myocardial ischemia and heart failure.

Benefits of technology

It improves the sensitivity and accuracy of heart detection, can reflect the heart status in a timely manner, accurately prompts the risk of myocardial ischemia and heart failure, provides timely alarm reminders, and improves the monitoring effect of heart disease patients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PI2025004190_DRAWING_001
    Figure PI2025004190_DRAWING_001
Patent Text Reader

Abstract

Disclosed in the present application are a cardiac test assessment method, system and apparatus, and a storage medium. The method comprises: collecting electrocardiogram signals of different patients, so as to identify abnormal data, wherein the abnormal data comprises at least one of abnormal heart rate data, abnormal electrocardiogram low-frequency component data, abnormal blood oxygen data, and abnormal blood pressure data; in response to the abnormal data, performing electrocardiogram high-frequency component analysis, so as to extract a first number of leads that meet a positive indicator, wherein the positive indicator indicates that a high-frequency morphology index of a corresponding lead is greater than a first threshold value; and determining the magnitudes of the first number of leads and a preset lead threshold value, wherein if the first number of leads is greater than the lead threshold value, an alarm reminder is outputted. Drawing accompanying abstract: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

Cardiac detection and evaluation method, system, storage medium and device

[0001] This application claims priority to Chinese patent application number 2023100325464, filed with the China Patent Office on January 10, 2023, entitled “Cardiac Detection and Evaluation Method, System, Storage Medium and Device,” the entire contents of which are incorporated herein by reference. Technical Field

[0002] The present application relates to the field of smart medical technology, and more specifically, to a cardiac detection and evaluation method, system, storage medium, and device. Background Art

[0003] An ECG monitor is a sophisticated medical instrument that can monitor a patient's heart rate, blood pressure, electrocardiogram, blood oxygen saturation, respiration, body temperature and other physiological parameters. It is widely used in ICUs, CCUs, operating rooms, wards and other places to enable real-time detection of patients.

[0004] Traditional ECG monitors primarily focus on the ST segment of cardiac repolarization and low-frequency ECG signals. They suffer from low sensitivity and accuracy in analyzing and monitoring a patient's heart health, making them ineffective in detecting heart problems and changes in their condition. This also hinders timely assessment of treatment effectiveness for hospitalized patients undergoing cardiac treatment. Summary of the Invention

[0005] According to the various embodiments disclosed in the present application, a heart detection and evaluation method, system, storage medium and device are provided. By further cooperating with the analysis of the high-frequency components of the electrocardiogram, the high-frequency components of the electrocardiogram can reach the microvolt level, which can timely reflect the heart status. The detection sensitivity and accuracy are high, and the risk of myocardial ischemia and heart failure problems can be accurately indicated.

[0006] The first aspect of the present application provides a cardiac detection and evaluation method, comprising the following steps:

[0007] Collecting ECG signals of different patients to identify abnormal data, wherein the abnormal data includes at least one of abnormal heart rate data, abnormal ECG low-frequency component data, abnormal blood oxygen data, or abnormal blood pressure data;

[0008] In response to the abnormal data, performing an electrocardiographic high-frequency component analysis, analyzing the QRS complex data in the electrocardiographic high-frequency component to extract the number of first leads that meet a positive indicator, wherein the positive indicator indicates that the high-frequency morphology index of the corresponding lead is greater than a first threshold;

[0009] The difference between the first number of leads and a preset lead threshold is determined, wherein if the first number of leads is greater than the lead threshold, an alarm is output.

[0010] In this embodiment, the method further includes obtaining a second number of leads, wherein the second number of leads corresponds to the number of leads in which the high-frequency QRS envelope curve formed by the high-frequency QRS wave group data in the resting state drops more than a preset second threshold value.

[0011] In this solution, the acquisition of ECG signals from different patients to identify abnormal data specifically includes:

[0012] Based on the preset acquisition module, the patient's physiological information is collected and converted into electrical signals and input into the preset electrocardiogram monitoring module for monitoring;

[0013] Monitoring the patient's blood pressure based on the blood pressure monitoring unit in the electrocardiogram monitoring module to identify abnormal blood pressure data;

[0014] Monitoring the patient's blood oxygen level based on the blood oxygen monitoring unit in the electrocardiogram monitoring module to identify abnormal blood oxygen level data;

[0015] Monitoring the patient's ECG based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data;

[0016] The heart rate monitoring unit in the electrocardiogram monitoring module monitors the patient's heart rate to identify abnormal heart rate data.

[0017] In this solution, the high-frequency component analysis based on the abnormal data is performed, and the QRS wave group data in the high-frequency component of the electrocardiogram is analyzed to extract the number of first leads that meet the positive indicator, specifically including:

[0018] Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve;

[0019] Obtaining the total area of ​​each amplitude reduction region in the high-frequency QRS envelope curve as a first total area, and obtaining the total area below the high-frequency QRS envelope curve as a second total area;

[0020] A ratio is calculated based on the first total area and the second total area to obtain a high-frequency morphology index, and the lead with the high-frequency morphology index greater than a first threshold is used as the positive indicator.

[0021] In this solution, the number of drops of the high-frequency QRS envelope curve formed by the high-frequency QRS wave group data in the resting state is obtained, including:

[0022] Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve;

[0023] Counting the peak-to-peak values ​​of each amplitude reduction region of the high-frequency QRS envelope curve of each lead, and determining the number of drops of the electrocardiogram signal in the resting state based on the total number of the peak-to-peak values; or

[0024] The area of ​​the region where the amplitude of each high-frequency QRS envelope curve decreases in each lead is calculated to obtain the number of drops in the ECG signal in the resting state.

[0025] In this solution, the method further includes identifying an area decrease value of the amplitude reduction region, and outputting an alarm when the area decrease value exceeds a preset decrease threshold.

[0026] A second aspect of the present application further provides a cardiac detection and evaluation system, comprising a memory and a processor, wherein the memory comprises a cardiac detection and evaluation method program, and when the cardiac detection and evaluation method program is executed by the processor, the following steps are implemented:

[0027] Collecting ECG signals of different patients to identify abnormal data, wherein the abnormal data includes at least one of abnormal heart rate data, abnormal ECG low-frequency component data, abnormal blood oxygen data, or abnormal blood pressure data;

[0028] In response to the abnormal data, performing an electrocardiographic high-frequency component analysis, analyzing the QRS complex data in the electrocardiographic high-frequency component to extract the number of first leads that meet a positive indicator, wherein the positive indicator indicates that the high-frequency morphology index of the corresponding lead is greater than a first threshold;

[0029] The difference between the first number of leads and a preset lead threshold is determined, wherein if the first number of leads is greater than the lead threshold, an alarm is output.

[0030] In this solution, when the processor executes the cardiac detection and evaluation method program, the following steps are also implemented:

[0031] A second number of leads is obtained, wherein the second number of leads corresponds to the number of leads in which the number of drops of the electrocardiogram signal in a resting state exceeds a preset second threshold.

[0032] In this solution, the acquisition of ECG signals from different patients to identify abnormal data specifically includes:

[0033] Based on the preset acquisition module, the patient's physiological information is collected and converted into electrical signals and input into the preset electrocardiogram monitoring module for monitoring;

[0034] Monitoring the patient's blood pressure based on the blood pressure monitoring unit in the electrocardiogram monitoring module to identify abnormal blood pressure data;

[0035] Monitoring the patient's blood oxygen level based on the blood oxygen monitoring unit in the electrocardiogram monitoring module to identify abnormal blood oxygen level data;

[0036] Monitoring the patient's ECG based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data;

[0037] The heart rate monitoring unit in the electrocardiogram monitoring module monitors the patient's heart rate to identify abnormal heart rate data.

[0038] In this solution, the high-frequency component analysis based on the abnormal data is performed, and the QRS wave group data in the high-frequency component of the electrocardiogram is analyzed to extract the number of first leads that meet the positive indicator, specifically including:

[0039] Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve;

[0040] Obtaining the total area of ​​each amplitude reduction region in the high-frequency QRS envelope curve as a first total area, and obtaining the total area below the high-frequency QRS envelope curve as a second total area;

[0041] A ratio is calculated based on the first total area and the second total area to obtain a high-frequency morphology index, and the lead with the high-frequency morphology index greater than a first threshold is used as the positive indicator.

[0042] In this solution, the number of drops of the high-frequency QRS envelope curve formed by the high-frequency QRS wave group data in the resting state is obtained, including:

[0043] Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve;

[0044] Counting the peak-to-peak values ​​of each amplitude reduction region of the high-frequency QRS envelope curve of each lead, and determining the number of drops of the electrocardiogram signal in the resting state based on the total number of the peak-to-peak values; or

[0045] The area of ​​the region where the amplitude of each high-frequency QRS envelope curve decreases in each lead is calculated to obtain the number of drops in the ECG signal in the resting state.

[0046] In this solution, the method further includes identifying an area decrease value of the amplitude reduction region, and outputting an alarm when the area decrease value exceeds a preset decrease threshold.

[0047] The third aspect of the present application provides a computer-readable storage medium, which includes a heart detection and evaluation method program for a machine. When the heart detection and evaluation method program is executed by a processor, the steps of the heart detection and evaluation method are implemented.

[0048] A fourth aspect of the present application provides a cardiac detection and evaluation device, which implements the cardiac detection and evaluation method described above, including:

[0049] A high-frequency QRS ECG analysis module, an ECG monitoring module wirelessly connected to the high-frequency QRS, and an acquisition module wirelessly connected to the ECG monitoring module, wherein:

[0050] The acquisition module includes a number of sensors for collecting the patient's physiological information and converting it into electrical signals for input into the ECG monitoring module;

[0051] The ECG monitoring module includes a blood pressure monitoring unit, a heart rate monitoring unit, a blood oxygen monitoring unit, and an ST segment ECG monitoring unit, which are used to monitor the vital signs of different patients based on the electrical signals input by the acquisition module;

[0052] The high-frequency QRS electrocardiogram analysis module is used to analyze the monitoring data input by the electrocardiogram monitoring module to output an alarm reminder.

[0053] The details of one or more embodiments of the present application are set forth in the accompanying drawings and the description below. Other features and advantages of the present application will become apparent from the description, drawings, and claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0054] In order to more clearly illustrate the technical solutions in the embodiments of the present application, the following briefly introduces the drawings required for use in the embodiments. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.

[0055] FIG1 shows a flow chart of a cardiac detection and evaluation method of the present application;

[0056] FIG2 is a schematic diagram showing an amplitude reduction region of a heart detection and evaluation method of the present application;

[0057] FIG3 shows a block diagram of a cardiac detection and evaluation system of the present application;

[0058] FIG4 shows a block diagram of a cardiac detection and evaluation system according to the present application. DETAILED DESCRIPTION

[0059] In order to more clearly understand the above-mentioned objects, features and advantages of the present application, the present application is further described in detail below in conjunction with the accompanying drawings and specific embodiments. It should be noted that the embodiments of the present application and the features therein can be combined with each other in the absence of conflict.

[0060] In the following description, many specific details are set forth to facilitate a full understanding of the present application. However, the present application may also be implemented in other ways different from those described herein. Therefore, the scope of protection of the present application is not limited to the specific embodiments disclosed below.

[0061] FIG1 shows a flow chart of a heart detection and evaluation method of the present application.

[0062] As shown in FIG1 , the present application discloses a heart detection and evaluation method, comprising the following steps:

[0063] S102, collecting ECG signals of different patients to identify abnormal data, wherein the abnormal data includes at least one of abnormal heart rate data, abnormal ECG low frequency component data, abnormal blood oxygen data, or abnormal blood pressure data;

[0064] S104, in response to the abnormal data, performing an ECG high-frequency component analysis, analyzing the QRS complex data in the ECG high-frequency component to extract the number of first leads that meet a positive indicator, wherein the positive indicator indicates that the high-frequency morphology index of the corresponding lead is greater than a first threshold;

[0065] S106: Determine the difference between the first number of leads and a preset lead threshold, wherein if the first number of leads is greater than the lead threshold, output an alarm.

[0066] It should be noted that, in this embodiment, the patient's physiological information is collected to generate electrical signals so as to identify abnormal data based on the electrocardiogram signals of different patients. Accordingly, the collected physiological information includes heart rate, blood pressure, etc. Therefore, the abnormal data at least includes abnormal heart rate data, abnormal electrocardiogram low-frequency component data, abnormal blood oxygen data and abnormal blood pressure data. In actual application, it can be a combination of one or more abnormal data, and high-frequency component analysis is performed based on the abnormal data, including extracting the number of first leads that meet the positive indicators for judgment, and comparing it with the lead threshold, wherein the lead threshold is "3". When the number of the first leads that meet the positive indicators is greater than "3", it can accurately indicate the risk of myocardial ischemia, thereby outputting the corresponding alarm reminder. For the description of the positive indicators, please refer to the subsequent description.

[0067] In the above-mentioned heart detection and evaluation method, by further coordinating with the analysis of the high-frequency components of the ECG, since the high-frequency components of the ECG can reach the microvolt level, it can timely reflect the heart status, with high detection sensitivity and high accuracy, and can accurately indicate the risk of myocardial ischemia and heart failure problems.

[0068] According to an embodiment of the present application, the method also includes obtaining a second number of leads, wherein the second number of leads corresponds to the number of leads in which the high-frequency QRS envelope curve formed by the high-frequency QRS wave group data in the resting state drops more than a preset second threshold.

[0069] It should be noted that, in this embodiment, the above embodiment describes the use of the first lead number to compare with the lead threshold to output an alarm reminder of myocardial ischemia, while in this embodiment, the second lead number is obtained for judgment. If the second lead number exceeds the second threshold, it can further indicate that the heart has a heart failure problem, wherein the second threshold is "3", and the second lead number is the number of times the ECG signal shows a downward trend, wherein the downward trend of the ECG signal is used to characterize the appearance of a reduced amplitude area (Reduced Amplitude Zone, RAZ) in the QRS waveform of the ECG signal corresponding to the resting state. As shown in Figure 2, the reduced amplitude area refers to the concave area S formed between point A and point B in the QRS waveform of the ECG signal corresponding to the resting state.

[0070] According to an embodiment of the present application, collecting ECG signals of different patients to identify abnormal data specifically includes:

[0071] Based on the preset acquisition module, the patient's physiological information is collected and converted into electrical signals and input into the preset electrocardiogram monitoring module for monitoring;

[0072] Monitoring the patient's blood pressure based on the blood pressure monitoring unit in the electrocardiogram monitoring module to identify abnormal blood pressure data;

[0073] Monitoring the patient's blood oxygen level based on the blood oxygen monitoring unit in the electrocardiogram monitoring module to identify abnormal blood oxygen level data;

[0074] Monitoring the patient's ECG based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data;

[0075] The heart rate monitoring unit in the electrocardiogram monitoring module monitors the patient's heart rate to identify abnormal heart rate data.

[0076] It should be noted that, in this embodiment, the abnormal data identified include abnormal blood pressure data, abnormal blood oxygen data and abnormal heart rate data. Specifically, the patient's blood pressure is monitored by the blood pressure monitoring unit in the ECG monitoring module to identify abnormal blood pressure data; and the patient's blood oxygen is monitored based on the blood oxygen monitoring unit in the ECG monitoring module to identify abnormal blood oxygen data; and the patient's ECG is monitored based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data; and the patient's ECG is monitored based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data.

[0077] According to an embodiment of the present application, the high-frequency component analysis based on the abnormal data and the QRS complex data in the high-frequency component of the electrocardiogram are analyzed to extract the number of first leads that meet the positive indicator, specifically including:

[0078] Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve;

[0079] Obtaining the total area of ​​each amplitude reduction region in the high-frequency QRS envelope curve as a first total area, and obtaining the total area below the high-frequency QRS envelope curve as a second total area;

[0080] A ratio is calculated based on the first total area and the second total area to obtain a high-frequency morphology index, and the lead with the high-frequency morphology index greater than a first threshold is used as the positive indicator.

[0081] It should be noted that, in this embodiment, the first threshold value is "15%". When the ratio of the first total area to the second total area is greater than "15%", it indicates that the current lead meets the positive indicator, wherein the first total area is the total area of ​​each amplitude reduction region of the electrocardiogram signal corresponding to the resting state; the second total area is the total area under the envelope of the electrocardiogram signal corresponding to the resting state.

[0082] According to an embodiment of the present application, obtaining the number of descents of a high-frequency QRS envelope curve formed by high-frequency QRS complex data in a resting state includes:

[0083] Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve;

[0084] Counting the peak-to-peak values ​​of each amplitude reduction region of the high-frequency QRS envelope curve of each lead, and determining the number of drops of the electrocardiogram signal in the resting state based on the total number of the peak-to-peak values; or

[0085] The area of ​​the region where the amplitude of each high-frequency QRS envelope curve decreases in each lead is calculated to obtain the number of drops in the ECG signal in the resting state.

[0086] It should be noted that in this embodiment, in a specific example, by counting the peak-to-peak values ​​of each amplitude reduction region of the ECG signal in the resting state, the total number of peak-to-peak values ​​of the ECG signal in the resting state can be determined as the number of times the ECG signal in the resting state shows a downward trend (alternatively, the number of times the ECG signal shows a downward trend can be counted by calculating the number of times the area of ​​each amplitude reduction region in each lead exceeds a preset threshold). By counting the number of times the ECG signal in the resting state shows a downward trend for each lead, and comparing the number of times the ECG signal in the resting state shows a downward trend for each lead with a second threshold, the number of leads whose number of times the ECG signal in the resting state shows a downward trend exceeding the second threshold can be obtained, i.e., the second number of leads. This analysis can further indicate the possibility of heart failure.

[0087] According to an embodiment of the present application, the method further includes identifying an area decrease value of the amplitude reduction region, and outputting an alarm when the area decrease value exceeds a preset decrease threshold.

[0088] It should be noted that, in this embodiment, the drop threshold is "40%". When the area drop value corresponding to a certain lead exceeds "40%", an alarm reminder needs to be output.

[0089] It should be understood that, although the various steps in the flowchart of FIG1 are shown in sequence as indicated by the arrows, these steps are not necessarily performed in the order indicated by the arrows. Unless otherwise specified herein, there is no strict order restriction on the execution of these steps, and these steps can be performed in other orders. Moreover, at least a portion of the steps in FIG1 may include multiple sub-steps or multiple stages, and these sub-steps or stages are not necessarily performed at the same time, but can be performed at different times. The execution order of these sub-steps or stages is not necessarily to be performed in sequence, but can be performed in turn or alternately with other steps or at least a portion of the sub-steps or stages of other steps.

[0090] FIG3 shows a block diagram of a heart detection and evaluation system of the present application.

[0091] As shown in FIG3 , the present application discloses a cardiac detection and evaluation system, including a memory and a processor. The memory includes a cardiac detection and evaluation method program. When the cardiac detection and evaluation method program is executed by the processor, the following steps are implemented:

[0092] Collecting electrocardiogram (ECG) signals from different patients to identify abnormal data, wherein the abnormal data includes at least abnormal heart rate data, abnormal blood oxygen data, and abnormal blood pressure data;

[0093] Performing a high-frequency component analysis based on the abnormal data, analyzing the QRS wave group data in the high-frequency component of the electrocardiogram to extract the number of first leads that meet a positive indicator, wherein the positive indicator indicates that the high-frequency morphology index of the corresponding lead is greater than a first threshold;

[0094] The difference between the first number of leads and a preset lead threshold is determined, wherein if the first number of leads is greater than the lead threshold, an alarm is output; otherwise, no alarm is output.

[0095] It should be noted that, in this embodiment, the patient's physiological information is collected to generate electrical signals so as to identify abnormal data based on the electrocardiogram signals of different patients. Accordingly, the collected physiological information includes heart rate, blood pressure, etc. Therefore, the abnormal data at least includes abnormal heart rate data, abnormal electrocardiogram low-frequency component data, abnormal blood oxygen data and abnormal blood pressure data. In actual application, it can be a combination of one or more abnormal data, and high-frequency component analysis is performed based on the abnormal data, including extracting the number of first leads that meet the positive indicators for judgment, and comparing it with the lead threshold, wherein the lead threshold is "3". When the number of the first leads that meet the positive indicators is greater than "3", it can accurately indicate the risk of myocardial ischemia, thereby outputting the corresponding alarm reminder. For the description of the positive indicators, please refer to the subsequent description.

[0096] According to an embodiment of the present application, when the heart detection and evaluation method program is executed by the processor, the following steps are further implemented:

[0097] A second number of leads is obtained, wherein the second number of leads corresponds to the number of leads in which the number of drops of the high-frequency QRS envelope curve formed by the high-frequency QRS wave group data in the resting state exceeds a preset second threshold.

[0098] It should be noted that, in this embodiment, the above embodiment describes the use of the first lead number to compare with the lead threshold to output an alarm reminder of myocardial ischemia, while in this embodiment, the second lead number is obtained for judgment. If the second lead number exceeds the second threshold, it can further indicate that the heart has a heart failure problem, wherein the second threshold is "3", and the second lead number is the number of times the ECG signal shows a downward trend, wherein the downward trend of the ECG signal is used to characterize the appearance of a reduced amplitude area (Reduced Amplitude Zone, RAZ) in the QRS waveform of the ECG signal corresponding to the resting state. As shown in Figure 2, the reduced amplitude area refers to the concave area S formed between point A and point B in the QRS waveform of the ECG signal corresponding to the resting state.

[0099] According to an embodiment of the present application, collecting ECG signals of different patients to identify abnormal data specifically includes:

[0100] Based on the preset acquisition module, the patient's physiological information is collected and converted into electrical signals and input into the preset electrocardiogram monitoring module for monitoring;

[0101] Monitoring the patient's blood pressure based on the blood pressure monitoring unit in the electrocardiogram monitoring module to identify abnormal blood pressure data;

[0102] Monitoring the patient's blood oxygen level based on the blood oxygen monitoring unit in the electrocardiogram monitoring module to identify abnormal blood oxygen level data;

[0103] Monitoring the patient's ECG based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data;

[0104] The heart rate monitoring unit in the electrocardiogram monitoring module monitors the patient's heart rate to identify abnormal heart rate data.

[0105] It should be noted that, in this embodiment, the abnormal data identified include abnormal blood pressure data, abnormal blood oxygen data and abnormal heart rate data. Specifically, the patient's blood pressure is monitored by the blood pressure monitoring unit in the ECG monitoring module to identify abnormal blood pressure data; and the patient's blood oxygen is monitored based on the blood oxygen monitoring unit in the ECG monitoring module to identify abnormal blood oxygen data; and the patient's ECG is monitored based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data; and the patient's ECG is monitored based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data.

[0106] According to an embodiment of the present application, the high-frequency component analysis based on the abnormal data and the QRS complex data in the high-frequency component of the electrocardiogram are analyzed to extract the number of first leads that meet the positive indicator, specifically including:

[0107] Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve;

[0108] Obtaining the total area of ​​each amplitude reduction region in the high-frequency QRS envelope curve as a first total area, and obtaining the total area below the high-frequency QRS envelope curve as a second total area;

[0109] A ratio is calculated based on the first total area and the second total area to obtain a high-frequency morphology index, and the lead with the high-frequency morphology index greater than a first threshold is used as the positive indicator.

[0110] It should be noted that, in this embodiment, the first threshold value is "15%". When the ratio of the first total area to the second total area is greater than "15%", it indicates that the current lead meets the positive indicator, wherein the first total area is the total area of ​​each amplitude reduction region of the electrocardiogram signal corresponding to the resting state; the second total area is the total area under the envelope of the electrocardiogram signal corresponding to the resting state.

[0111] According to an embodiment of the present application, obtaining the number of descents of a high-frequency QRS envelope curve formed by high-frequency QRS complex data in a resting state includes:

[0112] Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve;

[0113] Counting the peak-to-peak values ​​of each amplitude reduction region of the high-frequency QRS envelope curve of each lead, and determining the number of drops of the electrocardiogram signal in the resting state based on the total number of the peak-to-peak values; or

[0114] The area of ​​the region where the amplitude of each high-frequency QRS envelope curve decreases in each lead is calculated to obtain the number of drops in the ECG signal in the resting state.

[0115] It should be noted that in this embodiment, in a specific example, by counting the peak-to-peak values ​​of each amplitude reduction region of the ECG signal in the resting state, the total number of peak-to-peak values ​​of the ECG signal in the resting state can be determined as the number of times the ECG signal in the resting state shows a downward trend (alternatively, the number of times the ECG signal shows a downward trend can be counted by calculating the number of times the area of ​​each amplitude reduction region in each lead exceeds a preset threshold). By counting the number of times the ECG signal in the resting state shows a downward trend for each lead, and comparing the number of times the ECG signal in the resting state shows a downward trend for each lead with a second threshold, the number of leads whose number of times the ECG signal in the resting state shows a downward trend exceeding the second threshold can be obtained, i.e., the second number of leads. This analysis can further indicate the possibility of heart failure.

[0116] According to an embodiment of the present application, the method further includes identifying an area decrease value of the amplitude reduction region, and outputting an alarm when the area decrease value exceeds a preset decrease threshold.

[0117] It should be noted that, in this embodiment, the drop threshold is "40%". When the area drop value corresponding to a certain lead exceeds "40%", an alarm reminder needs to be output.

[0118] A third aspect of the present application provides a computer-readable storage medium, which includes a heart detection and evaluation method program. When the heart detection and evaluation method program is executed by a processor, the steps of the heart detection and evaluation method are implemented.

[0119] As shown in FIG4 , the fourth aspect of the present application provides a cardiac detection and evaluation device, which implements the cardiac detection and evaluation method described above, including:

[0120] A high-frequency QRS ECG analysis module, an ECG monitoring module wirelessly connected to the high-frequency QRS ECG analysis module, and an acquisition module wirelessly connected to the ECG monitoring module, wherein:

[0121] The acquisition module includes a number of sensors for collecting the patient's physiological information and converting it into electrical signals for input into the ECG monitoring module;

[0122] The ECG monitoring module includes a blood pressure monitoring unit, a heart rate monitoring unit, a blood oxygen monitoring unit, and an ST segment ECG monitoring unit, which are used to monitor the vital signs of different patients based on the electrical signals input by the acquisition module;

[0123] The high-frequency QRS electrocardiogram analysis module is used to analyze the monitoring data input by the electrocardiogram monitoring module to output an alarm reminder.

[0124] It should be noted that wireless communication is used between the acquisition module, the ECG monitoring module and the high-frequency QRS ECG analysis module to facilitate data transmission. In order to reduce the monitoring cost, a central monitoring mode can be adopted, that is, one high-frequency QRS ECG analysis module is communicated with multiple ECG monitoring modules, and each ECG monitoring module is used to monitor different patients. The communication method can be as follows: Method 1: The acquisition module inputs the collected ECG signals of different patients into the corresponding ECG monitoring module. The ECG monitoring module uploads the abnormal data detected to the high-frequency QRS ECG analysis module, and the high-frequency QRS ECG analysis module starts analysis. This working method can reduce the operating cost of the high-frequency QRS analysis module; Method 2: The acquisition module inputs the collected ECG signals of different patients into the corresponding ECG monitoring module. Each ECG monitoring module inputs the ECG data into the high-frequency QRS ECG analysis module. The high-frequency QRS ECG analysis module automatically adjusts the analysis frequency according to the patient's heart risk level (such as the number of positive leads exceeds "8", analysis is once every "30" minutes), according to the set time or according to the change trend of the number of positive leads in a certain period of time (such as the number of positive leads increases from "3" to "5"), and / or the number of first leads (from "3" to "5").

[0125] The present application discloses a cardiac detection and evaluation method, system, storage medium and device, which, by further cooperating with the analysis of high-frequency components of the electrocardiogram (ECG), can timely reflect the cardiac status because the high-frequency components of the ECG can reach the microvolt level. The detection has high sensitivity and accuracy, and can accurately indicate the risk of myocardial ischemia and heart failure.

[0126] In the several embodiments provided in this application, it should be understood that the disclosed devices and methods can be implemented in other ways. The device embodiments described above are merely schematic. For example, the division of the units is merely a logical function division. In actual implementation, there may be other division methods, such as: multiple units or components can be combined, or can be integrated into another system, or some features can be ignored or not executed. In addition, the coupling, direct coupling, or communication connection between the components shown or discussed can be through some interfaces, and the indirect coupling or communication connection of the devices or units can be electrical, mechanical or other forms.

[0127] The units described above as separate components may or may not be physically separated, and the components displayed as units may or may not be physical units; they may be located in one place or distributed across multiple network units; some or all of the units may be selected according to actual needs to achieve the purpose of the scheme of this embodiment.

[0128] In addition, all functional units in the embodiments of the present application can be integrated into one processing unit, or each unit can be a separate unit, or two or more units can be integrated into one unit; the above-mentioned integrated units can be implemented in the form of hardware or in the form of hardware plus software functional units.

[0129] Those skilled in the art will appreciate that all or part of the steps of the above-mentioned method embodiments may be implemented by hardware associated with program instructions, and the aforementioned program may be stored in a computer-readable storage medium. When the program is executed, the program executes the steps of the above-mentioned method embodiments. The aforementioned storage medium includes various media that can store program codes, such as mobile storage devices, read-only memories (ROMs), random access memories (RAMs), magnetic disks, or optical disks.

[0130] Alternatively, if the above-mentioned integrated unit of the present application is implemented in the form of a software functional module and sold or used as an independent product, it can also be stored in a computer-readable storage medium. Based on this understanding, the technical solution of the embodiment of the present application, or the part that contributes to the prior art, can be embodied in the form of a software product. The computer software product is stored in a storage medium and includes a number of instructions for enabling a computer device (which can be a personal computer, server, or network device, etc.) to execute all or part of the methods described in each embodiment of the present application. The aforementioned storage medium includes: various media that can store program codes, such as mobile storage devices, ROM, RAM, magnetic disks or optical disks.

Claims

1. A heart detection and evaluation method, characterized in that: include: Collecting ECG signals of different patients to identify abnormal data, wherein the abnormal data includes at least one of abnormal heart rate data, abnormal ECG low-frequency component data, abnormal blood oxygen data, or abnormal blood pressure data; In response to the abnormal data, performing an electrocardiographic high-frequency component analysis, analyzing the QRS complex data in the electrocardiographic high-frequency component to extract the number of first leads that meet a positive indicator, wherein the positive indicator indicates that a high-frequency morphology index of the corresponding lead is greater than a first threshold; Determining the difference between the first number of leads and a preset lead threshold, wherein if the first number of leads is greater than the lead threshold, outputting an alarm reminder; The method further includes: obtaining a second number of leads, wherein the second number of leads corresponds to the number of leads in which the number of drops of the high-frequency QRS envelope curve formed by the high-frequency QRS complex data in the resting state exceeds a preset second threshold; In response to the abnormal data, performing an electrocardiographic high-frequency component analysis, analyzing the QRS wave group data in the electrocardiographic high-frequency component to extract the number of first leads that meet the positive indicator, specifically includes: Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve; Obtaining the total area of ​​each amplitude reduction region in the high-frequency QRS envelope curve as a first total area, and obtaining the total area below the high-frequency QRS envelope curve as a second total area; Calculating a ratio based on the first total area and the second total area to obtain a high-frequency morphology index, and taking the lead with the high-frequency morphology index greater than a first threshold as the positive indicator; The number of descents of the high-frequency QRS envelope curve formed by obtaining the high-frequency QRS wave group data in the resting state includes: Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve; Counting the peak-to-peak values ​​of each amplitude reduction region of the high-frequency QRS envelope curve of each lead, and determining the number of drops of the electrocardiogram signal in the resting state based on the total number of the peak-to-peak values; or The area of ​​the region where the amplitude of each high-frequency QRS envelope curve decreases in each lead is calculated to obtain the number of drops in the ECG signal in the resting state.

2. A heart detection and evaluation method according to claim 1, characterized in that: The collecting of ECG signals of different patients to identify abnormal data specifically includes: Based on the preset acquisition module, the patient's physiological information is collected and converted into electrical signals and input into the preset electrocardiogram monitoring module for monitoring; Monitoring the patient's blood pressure based on the blood pressure monitoring unit in the electrocardiogram monitoring module to identify abnormal blood pressure data; Monitoring the patient's blood oxygen level based on the blood oxygen monitoring unit in the electrocardiogram monitoring module to identify abnormal blood oxygen level data; Monitoring the patient's ECG based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data; The heart rate monitoring unit in the electrocardiogram monitoring module monitors the patient's heart rate to identify abnormal heart rate data.

3. A heart detection and evaluation method according to claim 1, characterized in that: The method further comprises: Identify the area decrease value of the amplitude reduction region, and output an alarm reminder when the area decrease value exceeds a preset decrease threshold.

4. A heart detection and evaluation system, characterized in that: The system comprises a memory and a processor, wherein the memory comprises a heart detection and evaluation method program, and when the heart detection and evaluation method program is executed by the processor, the following steps are implemented: Collecting ECG signals of different patients to identify abnormal data, wherein the abnormal data includes at least one of abnormal heart rate data, abnormal ECG low-frequency component data, abnormal blood oxygen data, or abnormal blood pressure data; In response to the abnormal data, performing an electrocardiographic high-frequency component analysis, analyzing the QRS complex data in the electrocardiographic high-frequency component to extract the number of first leads that meet a positive indicator, wherein the positive indicator indicates that the high-frequency morphology index of the corresponding lead is greater than a first threshold; Determining the difference between the first number of leads and a preset lead threshold, wherein if the first number of leads is greater than the lead threshold, outputting an alarm reminder; The method further includes: obtaining a second number of leads, wherein the second number of leads corresponds to the number of leads in which the number of drops of the high-frequency QRS envelope curve formed by the high-frequency QRS complex data in the resting state exceeds a preset second threshold; In response to the abnormal data, performing an electrocardiographic high-frequency component analysis, analyzing the QRS wave group data in the electrocardiographic high-frequency component to extract the number of first leads that meet the positive indicator, specifically includes: Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve; Obtaining the total area of ​​each amplitude reduction region in the high-frequency QRS envelope curve as a first total area, and obtaining the total area below the high-frequency QRS envelope curve as a second total area; Calculating a ratio based on the first total area and the second total area to obtain a high-frequency morphology index, and taking the lead with the high-frequency morphology index greater than a first threshold as the positive indicator; The number of descents of the high-frequency QRS envelope curve formed by obtaining the high-frequency QRS wave group data in the resting state includes: Align, filter and average the QRS complex data in the high-frequency components of the ECG to form a high-frequency QRS envelope curve; Counting the peak-to-peak values ​​of each amplitude reduction region of the high-frequency QRS envelope curve of each lead, and determining the number of drops of the electrocardiogram signal in the resting state based on the total number of the peak-to-peak values; or The area of ​​the region where the amplitude of each high-frequency QRS envelope curve decreases in each lead is calculated to obtain the number of drops in the ECG signal in the resting state.

5. A cardiac detection and evaluation system according to claim 4, characterized in that: When the processor executes the cardiac detection and evaluation method program, the following steps are also implemented: Based on the preset acquisition module, the patient's physiological information is collected and converted into electrical signals and input into the preset electrocardiogram monitoring module for monitoring; Monitoring the patient's blood pressure based on the blood pressure monitoring unit in the electrocardiogram monitoring module to identify abnormal blood pressure data; Monitoring the patient's blood oxygen level based on the blood oxygen monitoring unit in the electrocardiogram monitoring module to identify abnormal blood oxygen level data; Monitoring the patient's ECG based on the ST segment ECG monitoring unit in the ECG monitoring module to identify abnormal ECG low-frequency component data; The heart rate monitoring unit in the electrocardiogram monitoring module monitors the patient's heart rate to identify abnormal heart rate data.

6. A cardiac detection and evaluation system according to claim 4, characterized in that: When the processor executes the cardiac detection and evaluation method program, the following steps are also implemented: Identify the area decrease value of the amplitude reduction region, and output an alarm reminder when the area decrease value exceeds a preset decrease threshold.

7. A computer-readable storage medium, characterized in that The computer-readable storage medium includes a cardiac detection and evaluation method program. When the cardiac detection and evaluation method program is executed by a processor, the steps of a cardiac detection and evaluation method according to any one of claims 1 to 3 are implemented.

8. A cardiac detection and evaluation device, said device implementing a cardiac detection and evaluation method according to any one of claims 1 to 3, characterized in that: include: A high-frequency QRS ECG analysis module, an ECG monitoring module wirelessly connected to the high-frequency QRS ECG analysis module, and an acquisition module wirelessly connected to the ECG monitoring module, wherein: The acquisition module includes a number of sensors for collecting the patient's physiological information and converting it into electrical signals for input into the ECG monitoring module; The ECG monitoring module includes a blood pressure monitoring unit, a heart rate monitoring unit, a blood oxygen monitoring unit, and an ST segment ECG monitoring unit, which are used to monitor the vital signs of different patients based on the electrical signals input by the acquisition module; The high-frequency QRS electrocardiogram analysis module is used to analyze the monitoring data input by the electrocardiogram monitoring module to output an alarm reminder.